HGH Somatropin vs. CJC-1295 + Ipamorelin
Head-to-head comparison based on the profiles in the PepCycle library.
| Attribute | HGH Somatropin | CJC-1295 + Ipamorelin |
|---|---|---|
| Class | Growth Hormone | Growth Hormone Secretagogue |
| Description | Recombinant human growth hormone identical to the natural pituitary hormone, used in research on growth, metabolism, and aging. | A synergistic growth hormone releasing combination. CJC-1295 (a GHRH analog) amplifies GH pulse amplitude while Ipamorelin (a ghrelin mimetic) increases GH pulse frequency, producing robust and sustained GH elevation with minimal side effects. |
| Dose in studies | 2-4 IU per day | 100 mcg CJC-1295 (no DAC) + 100-200 mcg Ipamorelin per injection |
| Frequency | Daily or 5-6 days per week | 1-3x daily (commonly before bed, optionally morning and post-workout) |
| Half-life | 3-4 hours | CJC-1295 (DAC): ~6-8 days | CJC-1295 (no DAC/Mod GRF): ~30 min | Ipamorelin: ~2 hours |
| Cycle length | 6-12 months continuous, reassess | 3-6 months on, 1 month off (or continuous at lower dose with periodic breaks) |
| Research level | 5/5 – Extensively researched | 2/5 – Limited research |
HGH Somatropin: full profile · CJC-1295 + Ipamorelin: full profile
Values from research literature – not medical advice.